What Is Oxytocin?
Oxytocin is a nine-amino-acid hormone made in the hypothalamus and released from the pituitary gland. Its best-known jobs are physical: it makes the uterus contract during labor and triggers milk let-down during breastfeeding. It also acts in the brain, which is why it gets called the "love hormone" or "bonding hormone."
As a drug, oxytocin has been used in obstetrics for decades. Pitocin is the synthetic version given in hospitals by IV drip. Separately, compounding pharmacies and peptide clinics now offer oxytocin as a nasal spray or a small subcutaneous injection for mood, anxiety, social connection and sexual function. Those uses are off-label.
Most people who reach this page are trying to work out a dose for a compounded 2 mg, 5 mg or 10 mg vial. We cover what the research has actually used and how strong that research is. For the vial and syringe math, see our oxytocin 5 mg dosing protocol.
- Oxytocin is FDA-approved only as an injection for labor and postpartum bleeding. Pitocin's boxed warning states it is not indicated for elective induction of labor.
- Nasal and subcutaneous oxytocin for anxiety, bonding or sexual function is off-label and not FDA-reviewed for those uses.
- Most human research used single intranasal doses of 18 to 40 IU. No trial has established a subcutaneous dose for wellness use.
- Headline findings have not held up well. The 2005 "oxytocin increases trust" result failed to replicate in two large registered studies, and a 290-child autism trial found no benefit over placebo.
- Short-term intranasal use looked safe in research. Long-term off-label use has no safety data.
| Common Name | Oxytocin (also sold as oxytocin acetate) |
| Structure | Nonapeptide (9 amino acids); C43H66N12O12S2, molecular weight 1007.19 |
| Class | Neuropeptide hormone |
| FDA-Approved Products | Pitocin and generic oxytocin injection (10 units/mL, IV or IM) |
| Approved Uses | Medically indicated labor induction or augmentation; adjunct in incomplete or inevitable abortion; third-stage labor and postpartum bleeding |
| Off-Label Forms | Compounded nasal spray; compounded subcutaneous injection (2–10 mg vials) |
| Half-Life | About 1 to 6 minutes in plasma (Pitocin label) |
| Research Doses | Mostly 18–40 IU intranasal, usually single doses |
| On Our Directory | 11 clinics list oxytocin |
How Does Oxytocin Work?
Oxytocin binds the oxytocin receptor, which sits in the uterus, breast tissue, and parts of the brain involved in social and emotional processing. In the uterus, the Pitocin label explains, it raises calcium inside muscle cells to drive contractions, and receptor numbers climb sharply late in pregnancy.
The label flags two properties that matter for anyone using it off-label. Oxytocin has built-in antidiuretic (water-retaining) and blood-pressure effects, because it differs from vasopressin by only two amino acids. And it is cleared fast: its plasma half-life is about 1 to 6 minutes.
The open question for off-label use is whether oxytocin given outside the brain actually gets into it. The evidence is mixed:
- In 11 people given 24 IU intranasally, oxytocin rose in both blood and spinal fluid. Blood levels peaked at 15 minutes, while spinal fluid took up to 75 minutes to rise significantly, and the two did not correlate.[1]
- In rhesus monkeys given labeled oxytocin, both nasal and IV routes delivered some to the spinal fluid. The nasal route was no better than IV.[2]
- A 2016 review argued that very little of an intranasal dose reaches spinal fluid while blood levels go well above normal, so effects on the gut, heart and reproductive tract are likely and may explain some findings.[3]
For subcutaneous injection, no published human study has measured how much reaches the brain.
What the Clinical Evidence Actually Shows
Oxytocin has a large research literature with many small studies and a poor record when the small results are retested at scale.
Trust and social behavior. A 2005 Nature study reported that intranasal oxytocin made people more willing to trust strangers with money in an investment game.[4] That paper launched the "trust hormone" idea. A large, preregistered replication that included one of the original authors found no effect on trust.[5] A second registered replication in 2026 (211 people), pooled with the first for 532 participants, again found no evidence that oxytocin increases trusting behavior.[6] A 2016 statistical review concluded that intranasal oxytocin studies are generally underpowered and that most published findings probably don't represent true effects.[7]
Social anxiety. In a randomized trial of 25 people with social anxiety disorder, 24 IU before exposure therapy sessions improved how participants rated their own appearance and speech performance. It did not improve symptoms, thinking patterns or daily impairment more than placebo did.[8] No larger trial has shown a benefit for social anxiety.
Psychiatric conditions overall. A 2013 meta-analysis of 19 clinical trials across autism, social anxiety, postnatal depression, OCD, schizophrenia, borderline personality disorder and PTSD found a small combined effect, but only autism showed a significant effect on its own, based on 68 participants.[9] Then came the largest test: a 24-week trial of 290 children and adolescents with autism, targeting 48 IU a day. Social function improved by almost the same amount on oxytocin and placebo.[10]
Sexual function. In a 22-week crossover trial, 30 women with sexual dysfunction used 32 IU intranasally before sex. Sexual function scores improved about as much on placebo as on oxytocin (26% versus 31% on the main measure), with no significant treatment effect.[11]
Pain. A 2023 meta-analysis of 15 studies found no effect of intranasal oxytocin on pain intensity or unpleasantness.[12] One small crossover study (18 healthy adults) found that 4 micrograms injected under the skin reduced heat pain on the injected arm only. It did not change pressure or mechanical pain, which points to a local skin effect rather than a brain effect.[13]
What the Evidence Does Not Show
- A subcutaneous dose for mood or social use. The one subcutaneous trial we found used 4 micrograms to test local pain, far below what compounded protocols use.[13]
- Long-term benefit. Most studies tested a single dose in a lab. The longest large trial, in autism, was negative.[10]
- Long-term safety of daily or every-other-day use for months.
- Sex-specific dosing. Early trials enrolled mostly men.[14]
- Bodybuilding or "anti-inflammatory" benefits in humans. We found no human trial supporting either use.
Typical Dosing — What the Research Has Used
No established off-label dose
Oxytocin's only FDA-approved doses are obstetric IV and IM doses given in hospital. No trial has established a safe and effective dose for anxiety, social, sexual or wellness use. The figures below describe research and community practice, not dosing guidance.
Approved obstetric dosing (for context). For labor, the Pitocin label calls for 10 units diluted in 1,000 mL and an IV infusion started at 0.5 to 1 milliunit per minute, raised slowly with continuous fetal monitoring. After delivery, 10 units can be given intramuscularly. These doses are measured in units and given only under hospital supervision.
Intranasal research doses. A review of 38 trials through 2010 found doses of 18 to 40 IU, mostly single doses, though some studies gave up to 182 doses.[14] Specific trials used 24 IU,[1][8] 32 IU[11] and a 48 IU daily target.[10] Across psychiatric trials, doses ranged from 15 IU to more than 7,000 IU.[9]
Subcutaneous research doses. One trial: 4 micrograms, as a single local injection.[13]
Community-reported subcutaneous doses. Compounded vials (commonly 2, 5 or 10 mg) are dosed in micrograms, with community-reported amounts ranging from about 50 to 500 micrograms given daily or every other day, often in 8- to 12-week cycles. None of these numbers comes from a published trial. Research doses are in IU and vials are labeled in mg; our oxytocin 5 mg protocol page shows the conversion and syringe volumes used in clinic protocols.
Side Effects
At research doses. A systematic review of 38 randomized trials covering 1,529 participants found that intranasal oxytocin at 18 to 40 IU, used short term, produced no reliable side effects compared with placebo. Participants couldn't tell which one they had received. The review also found three case reports of adverse reactions linked to misuse or longer-term use.[14] In the 24-week autism trial, adverse events were similar on oxytocin and placebo.[10]
From the Pitocin label (obstetric doses). Reported reactions in mothers include anaphylaxis, nausea, vomiting, heart rhythm problems, high blood pressure episodes, subarachnoid hemorrhage, postpartum bleeding and uterine rupture. The label warns that oxytocin's antidiuretic effect can cause water intoxication with seizures and coma, especially with long infusions and oral fluids, and that maternal deaths from water intoxication have been reported. Those risks come from large IV doses in labor, but the water-retaining property is the same molecule at any dose.
Practical cautions. The approved purpose of oxytocin is to make the uterus contract, so anyone who is or may be pregnant should not use it outside obstetric care. People with heart rhythm problems, high blood pressure or conditions affecting sodium balance should raise them with the prescriber.
Regulatory & Access Status
Access status as of October 2026
Oxytocin injection (Pitocin and generics) is FDA-approved for obstetric use only. Compounded nasal and subcutaneous oxytocin is prescription-only and used off-label. Eleven clinics in the MyPeptideMatch directory list oxytocin.
Drugs@FDA lists Pitocin and several generic oxytocin injections as current prescription products. A nasal spray, Syntocinon (application 012285), once held US approval but is listed as discontinued, so no approved intranasal oxytocin is currently marketed in the US. Nasal sprays and subcutaneous vials offered by clinics are compounded, which means the FDA has not reviewed them for safety, effectiveness or quality.
Oxytocin is not named on the WADA Prohibited List.
Sourcing & Safety
- Get it on prescription from a licensed compounding pharmacy. Ask whether the pharmacy is a 503A pharmacy or a 503B outsourcing facility, and request its testing documentation.
- Avoid "research use only" vials. They are not made to drug standards, and potency, purity and sterility are unverified.
- Follow the pharmacy's storage instructions. Ask for the beyond-use date of a mixed vial; compounded products don't carry the stability data of an approved drug.
- On reviews of specific telehealth brands: we don't rate or review clinics or telehealth services. The evidence on this page applies regardless of who prescribes it.
What Makes Oxytocin Different
Most compounds on this site are synthetic research peptides with no approved use. Oxytocin is a natural human hormone with a long FDA-approved obstetric track record, which makes its basic chemistry and acute safety at high doses well documented. What is not documented is whether small off-label doses do what clinics advertise.
It is also the compound on this site where the gap between popular reputation and replicated evidence is easiest to see. The trust finding, the autism hopes and the sexual-function claims each looked promising in small studies and weakened in larger or better-controlled ones.
Oxytocin vs. Other Peptides Discussed for Mood and Sexual Wellness
| Parameter | Oxytocin | PT-141 (bremelanotide) | Selank |
|---|---|---|---|
| What it is marketed for | Bonding, anxiety, sexual function | Sexual desire and arousal | Anxiety |
| FDA status | Approved for obstetric use only | Approved as Vyleesi for acquired HSDD in premenopausal women | Not approved |
| Common forms | Nasal spray, subcutaneous injection | Subcutaneous injection | Nasal spray (most reported) |
| Large human trials | Negative in autism; trust effect not replicated | Trials supported its FDA approval for HSDD | None published in English; mostly Russian literature |
FAQ
Is oxytocin FDA approved?
Yes, but only for obstetric use. Pitocin and generic oxytocin injection are approved to start or strengthen labor when there is a medical reason, to help empty the uterus after incomplete or inevitable miscarriage, and to control bleeding after delivery. Pitocin's boxed warning says it is not indicated for elective induction of labor. Use for anxiety, social connection, sexual function or wellness is off-label.
What oxytocin dose is used in research?
Most human studies used a nasal spray at 18 to 40 IU, usually as a single dose. Examples include 24 IU in a social anxiety trial, 32 IU before sex in a women's sexual function trial, and a 48 IU daily target in a large autism trial. One small study injected 4 micrograms under the skin to test local pain effects. No trial has established a dose for subcutaneous wellness use.
What is the oxytocin peptide dosage for subcutaneous injection?
There is no trial-established subcutaneous dose for social, mood or wellness use. Community-reported amounts for compounded vials range from roughly 50 to 500 micrograms, given daily or every other day, but those figures come from clinic and vendor protocols rather than published trials.
Is the oxytocin dose different for men and women?
No published trial has set separate doses by sex. About 79% of participants in early intranasal oxytocin trials were men, so there is less data on women. The main trial in women, on sexual function, used 32 IU, within the range used in men.
Does oxytocin help with anxiety or social confidence?
The evidence is weak. A small trial in social anxiety disorder found oxytocin improved how people rated their own speeches during exposure therapy but did not improve overall symptoms compared with placebo. The famous 2005 finding that oxytocin increases trust failed to replicate in two large later studies.
What are the side effects of oxytocin?
In short-term research at 18 to 40 IU intranasally, side effects were no different from placebo. At large IV obstetric doses, the Pitocin label warns of water intoxication with seizures, dangerous uterine contractions, high blood pressure and heart rhythm problems. Long-term off-label use has not been studied for safety.
Related Peptides & Comparisons
For sexual desire specifically, PT-141 is the peptide with an FDA-approved indication (as Vyleesi, for premenopausal women with acquired hypoactive sexual desire disorder). For anxiety, Selank is the peptide most often compared with oxytocin. Kisspeptin-10 is another hormone-axis neuropeptide studied for sexual and reproductive effects. For more options, see our guides to sexual wellness and hormone optimization.
References
- Striepens N, Kendrick KM, Hanking V, et al. "Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans." Sci Rep. 2013;3:3440. PMID: 24310737
- Lee MR, Scheidweiler KB, Diao XX, et al. "Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay." Mol Psychiatry. 2018;23(1):115-122. PMID: 28289281
- Leng G, Ludwig M. "Intranasal Oxytocin: Myths and Delusions." Biol Psychiatry. 2016;79(3):243-50. PMID: 26049207
- Kosfeld M, Heinrichs M, Zak PJ, et al. "Oxytocin increases trust in humans." Nature. 2005;435(7042):673-6. PMID: 15931222
- Declerck CH, Boone C, Pauwels L, et al. "A registered replication study on oxytocin and trust." Nat Hum Behav. 2020;4(6):646-655. PMID: 32514040
- Kroll CF, Schruers KRJ, Viechtbauer W, et al. "Absence of a meaningful effect of intranasal oxytocin on trusting behavior: a registered report with pooled equivalence testing." Cortex. 2026;198:208-233. PMID: 41880977
- Walum H, Waldman ID, Young LJ. "Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies." Biol Psychiatry. 2016;79(3):251-7. PMID: 26210057
- Guastella AJ, Howard AL, Dadds MR, et al. "A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder." Psychoneuroendocrinology. 2009;34(6):917-23. PMID: 19246160
- Bakermans-Kranenburg MJ, van I Jzendoorn MH. "Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy." Transl Psychiatry. 2013;3(5):e258. PMID: 23695233
- Sikich L, Kolevzon A, King BH, et al. "Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder." N Engl J Med. 2021;385(16):1462-1473. PMID: 34644471
- Muin DA, Wolzt M, Marculescu R, et al. "Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial." Fertil Steril. 2015;104(3):715-23.e4. PMID: 26151620
- Lopes S, Osório FL. "Effects of intranasal oxytocin on pain perception among human subjects: A systematic literature review and meta-analysis." Horm Behav. 2023;147:105282. PMID: 36463692
- Albinni B, Zimmerman M, Ross J, et al. "Subcutaneous Oxytocin Injection Reduces Heat Pain: A Randomized-Controlled Trial." J Pain. 2024;25(9):104547. PMID: 38642595
- MacDonald E, Dadds MR, Brennan JL, et al. "A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research." Psychoneuroendocrinology. 2011;36(8):1114-26. PMID: 21429671
This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.









